ABSTRACT Background: Inverse associations between dietary protein and hypertension have been reported, which may be attributed to specific amino acids. Objective: We examined whether the intake of glutamic acid, arginine, cysteine, lysine, or tyrosine was associated with blood pressure (BP) levels (n = 3086) and incident hypertension (n = 1810) in the Rotterdam Study. Design: We calculated BP levels in quartiles of amino acid intake as a percentage of total protein intake (% of protein) with adjustment for age, sex, BMI, smoking, alcohol intake, education, and dietary factors. Subsequently, we used Cox proportional models that included the same confounders to evaluate the associations between specific amino acid intake and hypertension incidence. Results: Glutamic acid contributed most to protein intake (21% of protein), whereas lysine provided 7%, arginine 5%, tyrosine 4%, and cysteine 1.5%. A higher intake of tyrosine (w0.3% of protein) was significantly related to a 2.4-mm Hg lower systolic BP (P-trend = 0.05) but not to diastolic BP (P = 0.35). The other amino acids were not significantly associated with BP levels in a cross-sectional analysis. During 6 y of follow-up (7292 person-years), 873 cases of hypertension developed. None of the amino acids were significantly associated with incident hypertension (HR: 0.81-1.18; P-trend . 0.2). Conclusion: Our data do not suggest a major role for glutamic acid, arginine, lysine, tyrosine, or cysteine intake (as % of protein intake) in determining population BP or risk of hypertension.
INTRODUCTION
There is a wide consensus that blood pressure (BP) 4 can be modified by means of diet and lifestyle modifications, such as weight loss, a reduction in salt intake, and a dietary pattern rich in fruit and vegetables, such as the Dietary Approaches to Stop Hypertension Trial diet (1) (2) (3) . There is also evidence of a beneficial association between dietary protein and BP (4) . In the wellcontrolled OmniHeart crossover trial, systolic BP of 164 healthy US adults consuming a high-protein (w50% from plant protein) diet for 6 wk decreased by 1.4 mm Hg compared with a diet high in carbohydrates (5) . Whether the type of protein has differential effects on BP is not yet clear (4) . In several observational studies, the association between protein intake and BP has been studied in more detail, and results suggest a beneficial association for plant protein, whereas no association was observed for animal protein (6) (7) (8) (9) . In an 8-wk crossover trial in 352 prehypertensive and hypertensive participants, however, soy protein and milk protein both had similar and significant effects on systolic BP (22.0 and 22.3 mm Hg, respectively) compared with carbohydrates (10) . Trial data on other types of protein are scarce (4) .
The mechanisms via which types of dietary protein may differentially influence BP are largely unknown, but amino acid composition could play a role. In the INTERMAP (INTERnational collaborative study of MAcronutrients, micronutrients and blood Pressure) study of 4680 adults from China, Japan, the United States, and the United Kingdom, it was observed that, among those consuming predominantly plant protein compared with animal protein, intake of glutamic acid made up a higher percentage of total protein (6) . A 2-SD higher intake of glutamic acid (4.7% of total protein) was associated with a 1.5-mm Hg lower systolic BP and a 1.0-mm Hg lower diastolic BP (P , 0.05) after adjustment for lifestyle and dietary factors (11) . The hypothesized mechanism for this association was that glutamic acid is a precursor for arginine, which in turn is a precursor for the vasodilator nitric oxide (12, 13) . Several other amino acids have also been hypothesized to be involved in BP regulation. Lysine may compete with arginine in the transport system in the gut and unfavorably affect BP (12, 14) , whereas cysteine may lower BP through binding with excess aldehydes (15) . Finally, tyrosine may influence the catecholamine mechanism by acting as a precursor of norepinephrine in the brain, thereby reducing cardiovascular sympathetic tone (16) . Essential amino acids [ie, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, and threonine (17)] cannot be synthesized by the body, and levels of these amino acids in the body may be modified by dietary intake. However, to our best knowledge, no plausible mechanisms have been described through which these amino acids could influence BP, with the possible exception of lysine.
Although dietary protein has been associated with BP, it remains unclear whether specific amino acids are associated with BP levels or the incidence of hypertension. Hence, in the current study, we examined whether dietary intakes of the individual amino acids glutamic acid, arginine, lysine, cysteine, and tyrosine were associated with BP levels and incidence of hypertension in the population of the Rotterdam Study.
SUBJECTS AND METHODS

The Rotterdam Study
The current analyses formed part of the Rotterdam Studya population-based cohort study that evaluated the occurrence and progression of chronic diseases and their risk factors in people aged $55 y (18) . In brief, between 1990 and mid 1993 all residents of a suburb of Rotterdam in this age category were invited to participate, and 7983 people (78%) responded. Participants were interviewed at home, and 89% was physically examined at the research center. Written informed consent was obtained from all participants. The medical ethics committee of Erasmus University approved the study protocol.
For the cross-sectional analysis of amino acid intake and BP levels, we excluded 559 of all 7983 participants because of incomplete dietary data, 601 participants because of missing BP data, 1135 participants because of a history of cardiovascular diseases or diabetes, and 2602 participants because of antihypertensive medication use, which left 3086 participants ( Figure 1) .
Of the original cohort, 6406 participants (79%) were reexamined in 1993-1995 and 1997-1999 . For the analysis regarding amino acid intake and incident hypertension, we excluded 243 participants because of incomplete dietary data, 637 participants with missing BP data at baseline or both follow-up measurements, 581 participants because of a history of cardiovascular diseases or diabetes, and 3135 participants with hypertension at baseline, which left 1810 participants ( Figure 1 ).
Dietary assessment
At baseline, participants completed a checklist at home about foods and drinks they had consumed at least twice a month during the preceding year as well as dietary habits, use of alimentary supplements, and prescribed diets. Next, during their visit to the research center, they underwent a standardized interview with a trained dietitian based on the checklist, using a computerized 170-item semiquantitative food-frequency questionnaire (FFQ), and taking seasonal variations in fruit, vegetable, and fish intakes into account (19) . For each item, the frequency was recorded in times per day, week, or month. A regular serving for each item was expressed in natural units (eg, a slice of bread or an apple), household measures (for example, cup or spoon) or grams (cooked vegetables or mixed dishes). These dietary data were converted into total energy intake and nutrient intakes per day using the Dutch Food Composition Table of 1993 (20) .
In a validation study, the FFQ was compared with fifteen 24-h food records collected over 1 y in 6 collection periods of 2 or 3 consecutive days and with 24-h urinary urea excretion during 4 nonconsecutive days (21) . In short, correlation coefficients between the FFQ and multiple food records were $0.52 for the following nutrients: total protein, plant protein, PUFAs, SFAs, total carbohydrates, polysaccharides, potassium, calcium, fiber, and magnesium (21) . Moreover, 83% of participants were categorized in the same or adjacent quintile of energy-adjusted total protein intake. None of the participants were classified in the extreme quintile. For energy-adjusted plant protein intake, 73% of participants were categorized in the same or adjacent quintile and 1.3% in the extreme quintile (21) . We extended the Dutch Food Composition (24) . When the total protein content of foods differed from the foods in the Dutch Food Composition Table, amino acid concentrations were adapted accordingly. For foods not chemically analyzed, the amino acid composition was estimated from foods for which data were available (eg, the amino acid composition of cheese was calculated based on the amino acid composition of milk), combined with standard recipes in the Netherlands. Finally, the amino acid data were linked to the dietary database of the Rotterdam Study. Amino acid composition (except glutamine and asparagine) could be calculated for 98% of foods included in the Dutch Food Composition Table. The intake of amino acids per participant was calculated by summing the amino acid content of all consumed food items.
BP measurements
BP measurements were taken at the research center by a trained research assistant at baseline and during follow-up examinations after 2 and 6 y (18, 25) . BP was measured in duplicate at the right upper arm by using a random-zero sphygmomanometer with a 32 3 17 cm cuff after the participant had been sitting quietly for $5 min. Systolic BP was recorded at the appearance of sounds (first-phase Korotkoff) and diastolic BP at the disappearance of sounds (fifth-phase Korotkoff). Systolic and diastolic BP were calculated as the average of the 2 measurements. Hypertension was defined as systolic BP $140 mm Hg or diastolic BP $90 mm Hg or the use of antihypertensive medication on indication of hypertension. At the research center, a physician ascertained the indication for which the medication had been prescribed.
Collection of risk factor data
Information on current health status, medical history, medication use, alcohol use, smoking behavior, and education was obtained by trained research assistants. Height and body weight were measured while the participants wore indoor clothing and no shoes. BMI was calculated as weight (in kg) divided by the square of height (in m). Information on prevalent cardiovascular disease-defined as verified history of myocardial infarction, coronary artery bypass graft surgery, or percutaneous transluminal coronary angiography and verified history of stroke or transient ischemic attack-was assessed during a home interview and verified in medical records at the office of the general practitioners. Diabetes mellitus was considered present if participants used antidiabetic medication or had a serum glucose concentration $11.1 mmol/L.
Data analysis
Data analysis was performed with the use of SAS version 9.1 (SAS Institute). Because absolute amino acid intakes are strongly correlated with total protein intake and, as a consequence, are strongly positively correlated with each other (in the current study: r = 0.81-0.99), we expressed amino acid intake as a percentage of total protein intake (% of protein). We refer to this relative intake of amino acids when "intake" is mentioned in the text and tables. To investigate whether the intakes of amino acids of interest and other characteristics were associated with the proportion of plant protein in the diet, we calculated these baseline characteristics in quartiles of plant to animal protein ratio. Baseline characteristics in the text and tables are presented as means with SDs, unless stated otherwise.
BP levels with 95% CIs were obtained by using general linear models in quartiles of amino acid intake (% of protein), with the lowest quartile as a reference group. Furthermore, amino acid intakes were included continuously in the full model to estimate BP difference per 0.5% of protein as amino acids. The first model included age (continuous) and sex. Model 2 additionally adjusted for BMI (continuous), education (low, intermediate, or high), smoking status (current, former, or never), and alcohol intake (tertiles). Model 3 (ie, full model) additionally adjusted for intakes of energy, carbohydrates, SFAs, PUFAs, fiber, calcium, magnesium, potassium, and sodium (all continuous).
The sample size for our prospective analysis on amino acid intake and hypertension incidence was smaller (n = 1810), and amino acid intake was therefore divided into tertiles. Participants met the case definition if they had a systolic BP $140 mm Hg or diastolic BP $90 mm Hg during the examination visit or when they reported the initiation of antihypertensive medication. For participants who did not develop hypertension during follow-up, we computed survival time as time from baseline to the end of study period (ie, 6-y examination visit). For participants who received a diagnosis of hypertension during the 2-y examination visit, we computed survival time as time from baseline until that date, divided by 2 (ie, midpoint of an individual's follow-up period). If hypertension was diagnosed for the first time during the 6-y examination visit, we took time until the 2-y visit plus half the time between the 2-y and 6-y visits. Concerning antihypertensive medication, only current use was assessed during the examination visits, and no starting dates were available that could be used for survival time calculation. Cox proportional hazard models were used to obtain HRs with 95% CIs for incident hypertension in tertiles of amino acid intake with use of the same models as in our cross-sectional analysis. The lowest tertile was used as a reference category. Furthermore, amino acid intakes were added continuously to the full model to estimate HRs per 0.5% of protein.
Because lysine may compete with arginine in the transport system in the gut (12, 14) , we hypothesized that a high intake of lysine compared with arginine might unfavorably influence BP. For this reason we additionally examined whether the ratio of these 2 amino acids was associated with BP level and the incidence of hypertension. Furthermore, we hypothesized that diet can especially modify blood concentrations of essential amino acids. Therefore, we performed a secondary analysis in which we calculated HRs with 95% CIs for incident hypertension in tertiles of essential amino acid intake.
To obtain a P value for trend, median values of the tertiles or quartiles of amino acid intake were assigned to individuals and entered continuously into the multivariate models. Two-sided P values ,0.05 were considered statistically significant.
RESULTS
Descriptive data
The mean age of 3086 Dutch adults included in our crosssectional analysis was 66 6 7 y, and w40% were men. They had a mean BMI of 26 6 3, and 56% of the participants were overweight. The mean BP at baseline was 135/73 mm Hg, and 38% of participants had a BP .140/90 mm Hg. Baseline characteristics across quartiles of relative plant protein intake are shown in Table 1 . With an increasing proportion of plant protein in the diet, the proportion of men was higher, whereas the percentage of current smokers, alcohol consumers, and overweight individuals was lower. Total energy, carbohydrate, PUFA, magnesium, and fiber intakes increased across quartiles of relative plant protein intake, whereas total protein, SFA, and calcium intakes decreased. Baseline characteristics of 1810 individuals included in our prospective analysis were similar, except for lower average BPs (ie, 122 6 12 mm Hg systolic and 69 6 9 mm Hg diastolic) because hypertensive participants were excluded at baseline. 
Amino acid intake
Glutamic acid contributed most to protein intake (21% of protein, 17 6 4 g/d), whereas lysine provided 7% (5.6 6 1.4 g/d), arginine 5% (4.3 6 1.1 g/d), tyrosine 4% (3.0 6 0.8 g/d), and cysteine 1.5% (1.2 6 0.3 g/d). Among those who consumed predominantly plant protein compared with animal protein, intakes of glutamic acid, arginine, and cysteine made up a higher percentage of protein, whereas the intake of lysine was lower and tyrosine intake was constant over quartiles (Table 1) . Variations in amino acid intakes were relatively small, and the differences in median intake between extreme quartiles ranged from 0.3% of protein for tyrosine to 2.5% of protein for glutamic acid ( Table 2 ).
Amino acid intake and blood pressure levels
Results for the associations between amino acid intake and BP are summarized in Table 2 . After adjustment for age, sex, lifestyle, and dietary factors, participants with a median intake of 3.8% of protein as tyrosine had a 2.4-mm Hg lower systolic BP than did participants with a median intake of 3.5% of protein as tyrosine (P-trend = 0.05), but no difference in diastolic BP (20.4 mm Hg; P-trend = 0.35). None of the other amino acids showed significant associations with BP (all P-trend . 0.10). However, although not significant, a positive linear trend was found for lysine (+1.7 mm Hg systolic BP and +1.0 mm Hg diastolic BP for 7.3% compared with 6.3% of protein; P-trend = 0.19 and 0.10, respectively). BP in the highest compared with the lowest quartile of the arginine to lysine ratio (0.86 compared with 0.71) did not differ significantly (21.6 mm Hg/20.3 mm Hg; P-trend . 0.3). When the intakes of the different amino acids were analyzed as continuous variables (expressed per 0.5% of protein), none of the associations were significant (all P . 0.11), except for tyrosine, for which we observed an inverse association with systolic BP (b = 24.31 mm Hg per 0.5% of protein; P = 0.03; see Supplemental Table S1 under "Supplemental data" in the online issue).
Amino acid intake and hypertension incidence
During 6 y of follow-up (7292 person-years), a total of 873 cases were identified. None of the amino acids were significantly related to the incidence of hypertension ( Table 3) . Participants with 7.2% of protein as lysine showed a nonsignificantly higher risk of incident hypertension compared with participants with 6.4% of protein as lysine (HR: 1.15; 95% CI: 0.93, 1.43; P-trend = 0.20). We observed a nonlinear inverse association between the ratio of arginine to lysine and risk of hypertension in the middle tertile (HR: 0.81; 95% CI: 0.67, 0.97) and in the highest tertile compared with the lowest tertile (HR: 0.86; 95% CI: 0.69, 1.07) (P-trend = 0.20). When the intake of different amino acids was analyzed as a continuous variable (expressed per 0.5% of protein), no significant associations with incidence of hypertension were observed (HRs: 0.87-1.09; all P . 0.05; see Supplemental Table S2 under "Supplemental data" in the online issue).
With regard to essential amino acids, none of these amino acids was significantly associated with incident hypertension (HRs: 0.91-1.10; all P-trend . 0.20; see Supplemental Table S3 under "Supplemental data" in the online issue).
DISCUSSION
In a general older Dutch population, we found no association of the habitual intake of glutamic acid, arginine, lysine, and cysteine (expressed as % of protein) with BP. We found a borderline significant inverse association between tyrosine intake and systolic BP, but not diastolic BP. None of the examined amino acids was related to 6-y risk of hypertension. The Rotterdam Study is a single-center population-based cohort study with extensive data collection, including a 170-item FFQ. This FFQ has been validated against fifteen 24-h food records (21) . Repeated food diaries may more accurately reflect total habitual protein intake, but are not a gold standard. Nonetheless, good agreement was found between both methods, with 83% of the participants being classified in the same or adjacent quintile of total energy-adjusted protein intake and none of the participants being classified in the extreme quintile. Misclassification of participants for protein intake could have biased the associations with BP in our study toward the null. Because of the good level of agreement between the FFQ and the 15-d food records and a correlation of w0.7 with urinary nitrogen, however, we do not think that misclassification has largely affected our results. An important BP determinant for which the analyses were not fully controlled is sodium intake, because our FFQ did not measure salt use during cooking or at the table. If this discretionary salt intake is correlated with the intake of the amino acids of interest, residual confounding from added salt may have biased inverse associations toward the null, whereas direct associations would be amplified.
Our estimate of amino acid intake was based on data from the chemical analysis of only 150 main foods (24) . This may have introduced measurement error because of potential changes in amino acid composition due to production processes (eg, production of cheese from milk). We cannot exclude that this has led to misclassification of participants, and dilution of the associations between amino acid intake and BP. Another possible explanation for the absence of associations between amino acids and BP or incident hypertension may be the small variation in amino acid intakes in our cohort of older Dutch adults. Furthermore, we studied amino acids as a proportion of total protein intake because absolute intakes were strongly intercorrelated in our study (r = 0.81-0.99). We cannot exclude the possibility that absolute rather than relative amino acid intakes are relevant with regard to BP. This question can only be addressed in randomized controlled trials.
Studies on the association between dietary amino acids and BP in humans are scarce. The relation between glutamic acid intake and BP was investigated in the INTERMAP Study in 4680 adults (11) . In that study, the mean glutamic acid intake was 20.1% of protein (15.7 g/d), ranging from 17.8% of protein in Japan to 24.1% of protein in China. After adjustment for dietary and lifestyle factors, systolic BP was 1.5 mm Hg lower with a 4.7% higher intake of protein (2 SD) as glutamic acid (P , 0.05). We could not confirm this association, possibly because the INTERMAP Study included participants from 4 different countries, which possibly explains the larger variation in glutamic acid intake (1 SD = 2.4% of protein) in comparison with our cohort (1 SD = 1.1% of protein).
We found no association between arginine intake and BP. Arginine is a precursor for the vasodilator nitric oxide (26) . In a meta-analysis of 11 trials, the systolic BP effect of arginine supplementation was 25.4 mm Hg (95% CI: 28.5, 22.3; P , 0.01) (27) . However, arginine doses in these studies ranged between 4 and 24 g/d, which exceeds average dietary intakes (eg, 4.3 6 1.1 g/d in the Rotterdam Study). In an observational study in 806 Dutch elderly men (mean age: w71 y), a nonsignificant lower systolic BP of w2 mm Hg (P = 0.25) was found, with a 2.2-g/d higher arginine intake (23) . In 1981 Finnish men with a mean age of 53 6 5 y, a 2.5-g/d higher arginine intake was related to a 2.6-mm Hg lower systolic BP (P = 0.07) (28) . In these studies, however, data were not adjusted for potential confounders.
In participants of the Rotterdam Study who consumed much plant protein compared with animal protein, the percentage of lysine intake was lower, whereas arginine intake was higher. Our results suggest an unfavorable relation between lysine intake and BP or hypertension incidence. Moreover, we observed a tendency toward a beneficial association with hypertension incidence for the ratio of arginine to lysine. This is in line with observational studies in which inverse associations between plant protein and BP were found, whereas no associations were observed for animal protein (6) (7) (8) (9) . However, our data were not statistically significant; therefore, we could not draw firm conclusions.
It has been proposed that tyrosine could act as a precursor of norepinephrine in the brain, which reduces sympathetic tone, thereby lowering BP (16) . However, in a trial in 13 mildly hypertensive adults, 2 wk of supplementation of 7.5 g/d tyrosine did not affect BP (29) . In the current study, we observed an inverse association of tyrosine with systolic BP levels, but not with diastolic BP or incidence of hypertension. Therefore, we cannot exclude the possibility that our findings for tyrosine are due to chance.
In conclusion, our data do not suggest a major role for glutamic acid, arginine, lysine, tyrosine, or cysteine intake (as a % of total protein) in determining population BP or risk of hypertension. Whether absolute intakes of these or other amino acids could influence BP is currently unknown. More prospective studies, preferably in populations with heterogeneous eating habits, and randomized controlled trials are needed to clarify the potential role of amino acids in the prevention of hypertension.
